Field Trip Health Ltd.
Field Trip is a global leader in the development and delivery of psychedelic therapies. With Field Trip Discovery, the Company’s research division, leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics, Field Trip Health clinics for psychedelic therapies operating and opening within North America and Field Trip Digital, the Company’s technology division, building the digital and technological tools to support psychedelic experiences and consciousness expansion, we help people, from those in treatment to those seeking accelerated personal growth, with a simple, evidence-based way to heal and heighten engagement with the world.
Field Trip Health Ltd. (FTRP)
Le 2 juin/June 2021
At the request of the company the common shares and warrants of Field Trip Health Ltd. will be delisted at market close on Friday June 4, 2021.
The shares and warrants will continue to trade on the TSX under the current symbols on Monday June 7, 2021.
À la demande de la société, les actions ordinaires et les bons de souscription de Field Trip Health Ltd. seront radiés à la clôture du marché le vendredi 4 juin 2021.